Understanding Clinical Trial Topline Data in Stock
Lately CLRB clinical trial data readout, brought stock price per share $2.7 to $3.2, changed 60%+ in one day. https://investor.cellectar.com/news/detail/320/cellectar-biosciences-announces-positive-topline-data-achieving-primary-endpoint-in-pivotal-clinical-study-of-iopofosine-i-131-in-waldenstroms-macroglobulinemia